Australia markets open in 4 hours 39 minutes

Intra-Cellular Therapies Inc (23I.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
61.50+0.50 (+0.82%)
As of 08:18AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-110,868
-139,674
-256,256
-284,126
-227,006
Depreciation & amortisation
526
528
656
533
528
Stock-based compensation
56,236
52,832
43,013
34,303
24,115
Change in working capital
-35,230
-29,577
-58,136
-6,353
-27,276
Accounts receivable
-49,612
-38,829
-55,033
-9,391
-10,765
Inventory
-22,426
-26,348
-15,972
-892
-7,056
Accounts payable
3,091
1,057
1,704
3,189
-1,923
Other working capital
-98,518
-124,468
-270,964
-259,869
-230,340
Other non-cash items
93
92
90
179
214
Net cash provided by operating activities
-98,249
-124,199
-270,186
-259,544
-230,073
Cash flows from investing activities
Investments in property, plant and equipment
-
-269
-778
-325
-267
Purchases of investments
-387,858
-415,269
-759,209
-224,575
-755,629
Sales/maturities of investments
526,309
521,079
631,614
505,244
275,601
Net cash used for investing activities
138,182
105,541
-128,373
280,344
-480,295
Cash flows from financing activities
Common stock issued
-
0
433,718
0
652,712
Net cash used provided by (used for) financing activities
24,159
17,810
455,159
11,519
664,177
Net change in cash
64,092
-848
56,600
32,319
-46,191
Cash at beginning of period
77,477
150,365
93,765
61,446
107,637
Cash at end of period
141,569
149,517
150,365
93,765
61,446
Free cash flow
Operating cash flow
-98,249
-124,199
-270,186
-259,544
-230,073
Capital expenditure
-
-269
-778
-325
-267
Free cash flow
-98,518
-124,468
-270,964
-259,869
-230,340